MacroGenics | MGNX - Créances Commerciales





Créances Commerciales Changement Date
AbbVie USD 12.59B 180M 2025-12
Amgen USD 9.14B 432M 2026-03
AstraZeneca USD 17.88B 1.17B 2026-03
Biogen USD 1.79B 76.6M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Daiichi Sankyo JPY 695.95B 79.1B 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Genmab DKK 1.17B 119M 2025-12
Geron USD 37.66M 1.71M 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
J&J USD 21.33B 3.72B 2025-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
MacroGenics USD 13.37M 55.86M 2025-12
Merck USD 11.78B 345M 2025-12
Pfizer USD 15.84B 2.27B 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Xencor USD 29.3M 7.49M 2025-12